Q2 2019 Holdings
Filed 2019-08-14 | 81 holdings | $224.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $151.3M | 1,068,832 | 67.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $36.2M | 690,870 | 16.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $20.5M | 425,000 | 9.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.3M | 97,191 | 3.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $4.9M | 39,900 | 2.2% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $405.5K | 8,752,254 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $284.5K | 22,792,634 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $210.3K | 10,359,666 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $130.5K | 1,669,525 | 0.1% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $112.5K | 2,972,167 | 0.1% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $109.6K | 8,729,142 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $99.7K | 2,300,301 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $97.0K | 8,244,896 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $92.5K | 4,600,917 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $76.8K | 1,945,200 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $76.5K | 888,705 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $75.7K | 1,669,400 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $75.2K | 1,166,032 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $71.5K | 1,391,376 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $71.0K | 2,719,707 | 0.0% |
| Wright MED Group N V | ORD SHS | N96617118 | $70.7K | 2,372,157 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $66.0K | 1,612,798 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $62.6K | 412,000 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $51.8K | 183,500 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $51.5K | 557,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $51.5K | 3,462,300 | 0.0% |
| Array Biopharma Inc | NOTE 2.625%12/0 | 04269XAB1 | $50.2K | $16,500,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $50.1K | 2,223,376 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $46.3K | 2,920,389 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $43.5K | 1,080,300 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $35.8K | 3,215,994 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $34.6K | 141,901 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $34.4K | 609,658 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $34.3K | 3,000,641 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $33.5K | 3,620,376 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $33.3K | 813,500 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $32.2K | 2,197,003 | 0.0% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $30.7K | 461,880 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $30.5K | 423,987 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $30.3K | 13,954,794 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $29.8K | 1,021,808 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $27.3K | 878,403 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $27.2K | 740,671 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $25.8K | 172,100 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $25.7K | 1,799,216 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $24.7K | 1,796,477 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $24.0K | 168,387 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $23.9K | 2,008,447 | 0.0% |
| Alder Biopharmaceuticals Inc | NOTE 2.500% 2/0 | 014339AA3 | $23.2K | $25,000,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $22.5K | 3,138,365 | 0.0% |